Egyptian Pharma Startup i’SUPPLY Secures Impressive Pre-Series A Funding Boost

• Egyptian Pharma Startup i’SUPPLY raises pre-Series A funding, totaling US$2.5 million since its 2022 launch
• Funding round included Disruptech Ventures, OneStop Capital, Axian Investment CVC, and Egypt Ventures
• i’SUPPLY’s platform connects 10,000 pharmacies with 200 distribution companies, offering 10,000+ pharmaceutical products
• CEO Ibrahim Emam aims to obtain a license to address financing needs of small pharmacies
• Egypt Ventures CEO Abdel Rahman Mansour praises i’SUPPLY’s digital platform and strategic vision for industry impact

Egyptian Pharma Startup i’SUPPLY Secures Pre-Series A Funding

In the fast-evolving landscape of pharmaceutical distribution, Egyptian startup i’SUPPLY has made significant strides by recently announcing the successful closure of a pre-Series A funding round. This milestone marks a pivotal moment for the company, propelling its total funding to an impressive US$2.5 million since its inception in 2022. The funding round saw the participation of prominent investment funds, including Disruptech Ventures, OneStop Capital, Axian Investment CVC, and Egypt Ventures, underscoring the industry’s confidence in i’SUPPLY’s innovative approach and growth potential.

Revolutionizing Pharmaceutical Distribution in Egypt

At the core of i’SUPPLY’s operations is a technologically advanced platform that offers a diverse portfolio of over 10,000 pharmaceutical products. By leveraging this platform, the startup has successfully connected more than 10,000 pharmacies with over 200 small-to-medium-sized distribution companies, streamlining the supply chain and enhancing accessibility to essential medications for patients across Egypt. The strategic alignment between technology and healthcare underscores i’SUPPLY’s commitment to driving efficiency and addressing critical gaps in the pharmaceutical sector.

Empowering Small and Medium-Sized Pharmacies

Ibrahim Emam, the CEO and co-founder of i’SUPPLY, expressed his enthusiasm for the recent funding round, emphasizing the company’s dedication to empowering small and medium-sized pharmacies. Emam highlighted the startup’s ambitious plans to secure a license from the Egyptian Financial Regulatory Authority, a move that aims to cater to the evolving financing needs of pharmacies and distributors. By bridging the gap in working capital shortages and providing financial solutions tailored to the industry’s demands, i’SUPPLY is poised to make a lasting impact on the healthcare ecosystem in Egypt.

Related Video

Published on: March 7, 2019 Description:

Inno pharma startup (Jordan)

Strategic Partnerships Fueling Growth

Abdel Rahman Mansour, CEO of Egypt Ventures, underscored the importance of collaboration and strategic partnerships in driving i’SUPPLY’s growth trajectory. Mansour commended the startup’s innovative and fully digital platform, recognizing its potential to enhance operational efficiencies and optimize processes within the pharmaceutical supply chain. The endorsement from Egypt Ventures further solidifies i’SUPPLY’s position as a frontrunner in the Egyptian pharmaceutical distribution market, setting the stage for expanded capabilities and accelerated expansion plans in the near future.

I’SUPPLY’s successful fundraising efforts underscore its commitment to innovation, efficiency, and sustainability in the pharmaceutical distribution sector. With a strong investor backing and a clear strategic vision, the startup is well-positioned to lead the charge in transforming healthcare delivery and accessibility in Egypt. As i’SUPPLY continues to leverage technology and strategic partnerships to drive its mission forward, the future looks bright for this pioneering Egyptian pharma startup.